z-logo
open-access-imgOpen Access
Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria
Author(s) -
Magen Eli,
Komarova Irina,
Magen Israel,
Phirtskhalava Sofia
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5930
Subject(s) - benralizumab , medicine , immunology , dermatology , intensive care medicine , asthma , mepolizumab , eosinophil
The role of IL‐5 in chronic spontaneous urticarial (CSU) is unclear. It may be that benralizumab is an important bidirectional modifier of CSU; that is, blocking IL‐5 may improve CSU in some patients, but it is possible that it may worsen CSU in others.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here